|By Marketwired .||
|March 28, 2014 04:15 PM EDT||
LONGMONT, CO -- (Marketwired) -- 03/28/14 -- MediJane Holdings Inc. (OTCQB: MJMD) ("MediJane" or "MJMD" or the "Company") is pleased to announce that it has become a member and sponsor of the National Cannabis Industry Association (NCIA).
The NCIA is the only national trade association dedicated to advancing the interests and standardization of a safe, legal, and responsible cannabis industry. NCIA is leading the unified and coordinated campaign to ensure this emerging sector is treated fairly under federal law and to promote the growth of a responsible and legitimate cannabis industry. NCIA currently runs the only cannabis industry Political Action Committee in the country.
Mr. Ronald Lusk, CEO of MediJane Holdings Inc., commented, "The National Cannabis Industry Association was founded on the basic principle of power in numbers. Today, the growing number of American businesses involved in the state-legal cannabis industries represent what we believe to be a newly established economic force in this country. It is this ideal that attracted MediJane to join the NCIA to align ourselves with other leading and like-minded companies and professional organizations in such a rapidly developing industry."
MediJane Holdings' membership in the National Cannabis Industry Association means being represented alongside other top businesses committed to building a strong and prosperous future for cannabis-based enterprises. In addition to enhanced political representation, NCIA membership offers unparalleled networking opportunities, elevated national brand awareness and industry recognition, exclusive access to in-depth analysis of the cannabis industry and an information portal, monthly newsletter, exclusive events, and discounts.
For additional information regarding the National Cannabis Industry Association, visit www.thecannabisindustry.org.
About MediJane Holdings Inc. (MJMD)
MediJane Holdings Inc. (MJMD) is in the business of marketing and distributing products within the medicinal marijuana industry, including transdermal patches, capsules, sublingual sprays, and other medical delivery systems. With sales offices opening in California and Colorado, and a planned expansion into a national footprint, MediJane products are designed to give doctors the ability to provide patients accurate and effective doses of cannabinoids to manage and treat pain and other specific illnesses. MediJane's lead product is an innovative non-drowsy "Daytime Pain plus CBD" oral capsule for the treatment of inflammation and chronic, neuropathic, arthritic, and back pain. This smokeless and accurate dose alternative is MediJane's initial launch into the chronic pain management market, which is estimated at over $45 billion annually in North America.
For more information, visit www.medijaneholdings.com
Disclaimer/Safe Harbor: Some information in this MediJane Holdings Inc. (MJMD) press release constitutes forward-looking statements or statements which may be deemed or construed to be forward-looking statements. The words "plan", "forecast", "anticipates", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to, known and unknown risks, uncertainties and other factors which could cause MJMD's actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in the Company's filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to MJMD herein are expressly qualified in their entirety by the above-mentioned cautionary statement. MJMD disclaims any obligation to update forward-looking statements contained in this press release, except as may be required by law.